Close
Show

Production & Manufacturing

Production & Manufacturing

Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology


Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics"...